TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened September 26, 1980
TCL Archive Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs. November 12, 2004
